7731 - 7740 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Glutamate Receptors as Therapeutic Targets for Parkinsons DiseaseJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 8Issue #: 6Start Page: 475End Page: 491Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152709789824606Best OA location URL: https://europepmc.org/articles/pmc3005251?pdf=renderCitation Count: 223
- Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa2009OPENTitle: Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North AfricaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 477Issue #: 2Start Page: 57End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2009.11.066Best OA location URL: https://europepmc.org/articles/pmc2970621?pdf=renderCitation Count: 24
-
OPENTitle: Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysJournal Name: SynapsePublisher: WileyVol: 64Issue #: 3Start Page: 251End Page: 266Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/syn.20725Best OA location URL: https://europepmc.org/articles/pmc3821045?pdf=renderCitation Count: 21
-
OPENTitle: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s diseaseJournal Name: BiomarkersPublisher: Informa UK LimitedVol: 14Issue #: 7Start Page: 493End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3109/13547500903108423Best OA location URL: https://europepmc.org/articles/pmc2824250?pdf=renderCitation Count: 106
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: function in cells and neurodegenerationJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6436End Page: 6444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07342.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-4658.2009.07342.xCitation Count: 32
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic rolesJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6445End Page: 6454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07343.xBest OA location URL: https://europepmc.org/articles/pmc2827245?pdf=renderCitation Count: 21
-
OPENTitle: VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 330End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.10.011Best OA location URL: https://europepmc.org/articles/pmc2818321?pdf=renderCitation Count: 73
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://europepmc.org/articles/pmc2839805?pdf=renderCitation Count: 383
-
OPENTitle: Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulumJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 390Issue #: 3Start Page: 758End Page: 762Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2009.10.045Best OA location URL: https://europepmc.org/articles/pmc3014991?pdf=renderCitation Count: 54
- MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's disease2009OPENTitle: MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's diseaseJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 9Issue #: 2Start Page: 173End Page: 181Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1601-183x.2009.00542.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1601-183X.2009.00542.xCitation Count: 98